Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Storage and handling to maximize value When paying out of pocket, every dose matters
Peptides may also have potential side effects, such as nausea, vomiting, and diarrhea
The specific reactions users report most often: Compare this to actual GLP-1 receptor agonists, where nausea affects 20 to 44% of users, vomiting 5 to 24%, and constipation 12 to 24% across the STEP 1 and SURMOUNT-1 trial programs
Retatrutide is an investigational triple hormone receptor agonist being developed by Eli Lilly
US$ 22.52
US$ 29.65
US$ 27.80
US$ 26.55
